Veraxa Biotech AG (VRXA)

NASDAQ

$1,47

$--

(0,00%)

Pre-Market

Veraxa Biotech AG (VRXA) Live Price Chart

Last updated: ⁦2026-09-21 10:36:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Veraxa Biotech AG (VRXA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1,47, with a market capitalization of $206,46M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,27 to $27,36. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$206,46M
Open	$1,47
Day's High	$27,36
Day's Low	$1,27
Previous Close	$1,46
Volume	179,00
Average Volume	542,23K
P/E Ratio	--
52-Week High	$27,36
52-Week Low	$1,27
Dividend Yield	--
Earnings Date	--

Veraxa Biotech AG (VRXA) Pre-Market Stock Price

Veraxa Biotech AG (VRXA) is trading at $1,47 in pre-market trading as of 2026-09-21 10:03:00, up 0,68% ($0,01) from the previous close of $1,46

Pre-market trading shows how investors are pricing VRXA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Veraxa Biotech AG (VRXA) 7-Day Stock Price Change

Over the past seven days, Veraxa Biotech AG (VRXA) moved from $1,65 to $1,47, representing a decline of 10,91% ($0,18).

The stock traded between $1,45 and $1,72 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 102,56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VRXA 52-Week Price Position

Position in Range: 0,8%

52W Low$1,27

52W High$27,36

VRXA is currently trading at $1,47, placing it 0,8% of the way from its 52-week low of $1,27 to its 52-week high of $27,36. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Veraxa Biotech AG (VRXA)?

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Veraxa Biotech AG Information

Exchange	NASDAQ
Company Website	https://www.veraxa.com

How to Buy Veraxa Biotech AG (VRXA) Stock on MEXC

Eligible investors can buy real shares of Veraxa Biotech AG (VRXA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VRXA and Place Your Order

Open the RealStocks trading page and search for VRXA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Veraxa Biotech AG (VRXA) stock price today?

Veraxa Biotech AG (VRXA) is currently trading at $ 1,47, up 0,68% ($0,01) from the previous close of $ 1,46. Intraday prices update in real time during regular trading hours.

2.Is VRXA stock going up or down today?

As of 2026-09-21 10:03:00, VRXA is trading at $ 1,47, up 0,68% ($0,01) from its previous close of $ 1,46. The stock has traded between $ 1,27 and $ 27,36 during today’s regular session. Past price movements do not guarantee future results.

3.What is VRXA pre-market price?

As of 2026-09-21 10:03:00, VRXA is trading at $ 1,47 in pre-market trading, up 0,68% ($0,01) from the previous close of $ 1,46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VRXA after-hours price?

As of 2026-09-21 10:03:00, VRXA is trading at $ 1,47 in after-hours trading, up 0,68% ($0,01) from the regular-session close of $ 1,46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VRXA stock trading now?

VRXA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VRXA sit relative to its 52-week high and low?

Over the past 52 weeks, VRXA has traded between a low of $ 1,27 and a high of $ 27,36. At $ 1,47, the stock is positioned 0,8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Veraxa Biotech AG in?

Veraxa Biotech AG (VRXA) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Veraxa Biotech AG's market capitalization and where is it listed?

Veraxa Biotech AG is listed on the NASDAQ exchange with a market capitalization of $ 206,46M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VRXA valued in terms of P/E ratio and EPS?

VRXA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Veraxa Biotech AG pay a dividend?

Veraxa Biotech AG pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.